US Patent Issued to Milestone Pharmaceuticals on March 25 for "Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker" (Canadian Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,224, issued on March 25, was assigned to Milestone Pharmaceuticals Inc. (Montreal, Canada).

"Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker" was invented by Francis Plat (Saint-Laurent, Canada) and Douglas Wight (Saint-Laurent, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to methods of treating cardiac arrhythmia, angina, or a migraine in a patient in need thereof, with a therapeutically effective amount of a compound having a structure according to the formula:the method comprising nasally administering to the patient (i) a first dose, an...